Prospective hospital based study on persistent diarrhoea

P Dutta1, M Lahiri, D Sen

  • 1Department of Clinical Medicine, National Institute of Cholera and Enteric Diseases, Calcutta, India.

Gut
|July 1, 1991
PubMed

Insights

Persistent diarrhea affects 12.5% of young children, with increased risk in infants aged 7-18 months and those with malnutrition. Key pathogens include Shigella and Salmonella.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Gastroenterology

Background:

  • Acute diarrhea and dysentery are common childhood illnesses.
  • Persistent diarrhea poses a significant health risk to young children.

Purpose of the Study:

  • To determine the incidence of persistent diarrhea in children under 5 years old.
  • To identify risk factors and associated pathogens for persistent diarrhea.

Main Methods:

  • A hospital-based study of 383 children under 5 years with acute watery diarrhea or dysentery.
  • Defined persistent diarrhea as lasting 14 days or more.
  • Analyzed demographic, nutritional, clinical, and microbiological data.

Main Results:

  • 12.5% of children experienced persistent diarrhea (≥14 days).
  • Increased incidence of persistent diarrhea was observed in children aged 7-18 months.
  • Grade II-IV malnutrition was prevalent (70.8%) in persistent diarrhea cases.
  • Shigella flexneri, Shigella dysenteriae 1, and Salmonella typhimurium were more frequently isolated in persistent diarrhea cases.
  • No correlation found between disease severity at admission, measles, and persistent diarrhea.
  • Breastfeeding was associated with a lower risk of persistent diarrhea.

Conclusions:

  • Persistent diarrhea is a significant complication in young children, particularly those aged 7-18 months and with malnutrition.
  • Specific bacterial pathogens are associated with persistent diarrhea.
  • Breastfeeding appears to be protective against persistent diarrhea.

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...